MiniMed Group, Inc. (MMED)
NASDAQ
Real-time Data
01:30 PM
Day's Range
19.8652 wk Range
10.65Overview - MMED - MiniMed Group, Inc.
Key Statistics
Valuation
Enterprise Value
5.49B
P/E (Trailing)
‪-15.72‬
P/E (Forward)
‪31.21‬
PEG Ratio
‪31.21‬
Price / Sales (TTM)
‪1.85‬
Price / Book
‪1.59‬
EV / EBITDA
‪19.77‬
Profitability
Gross Margin
‪57.34%‬
Profit Margin
‪-10.73%‬
Operating Margin
‪8.36%‬
Return on Assets
‪1.72%‬
Return on Equity
‪-9.13%‬
Ownership
Shares Outstanding
280.81M
Float
27.44M
Short % of Shares Outstanding
‪21.50%‬
Held by Insiders
‪90.72%‬
Held by Institutions
‪13.37%‬
Price stats
50-Day Avg
‪16.87‬
200-Day Avg
‪15.11‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Average price target
‪$ 20.83‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MMED - MiniMed Group, Inc.
Peers - MMED - MiniMed Group, Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
Profile Summary - MMED - MiniMed Group, Inc.
About
MiniMed Group, Inc. is a global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for diabetes management. It offers a connected ecosystem of products including automated insulin delivery systems like the MiniMed 780G system with SmartGuard technology for real-time…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
